- Home
- CHRS vs SFBC Comparison
CHRS vs SFBC Comparison
Compare CHRS & SFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- SFBC
- Stock Information
- Founded
- CHRS 2010
- SFBC 1953
- Country
- CHRS United States
- SFBC United States
- Employees
- CHRS N/A
- SFBC N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- SFBC Savings Institutions
- Sector
- CHRS Health Care
- SFBC Finance
- Exchange
- CHRS Nasdaq
- SFBC Nasdaq
- Market Cap
- CHRS 102.0M
- SFBC 112.5M
- IPO Year
- CHRS 2014
- SFBC N/A
- Fundamental
- Price
- CHRS $1.05
- SFBC $46.55
- Analyst Decision
- CHRS Buy
- SFBC
- Analyst Count
- CHRS 3
- SFBC 0
- Target Price
- CHRS $4.68
- SFBC N/A
- AVG Volume (30 Days)
- CHRS 1.5M
- SFBC 4.9K
- Earning Date
- CHRS 08-07-2025
- SFBC 07-29-2025
- Dividend Yield
- CHRS N/A
- SFBC 1.63%
- EPS Growth
- CHRS N/A
- SFBC 59.31
- EPS
- CHRS 1.55
- SFBC 2.43
- Revenue
- CHRS $272,209,000.00
- SFBC $38,045,000.00
- Revenue This Year
- CHRS N/A
- SFBC N/A
- Revenue Next Year
- CHRS $142.61
- SFBC N/A
- P/E Ratio
- CHRS $2.05
- SFBC $19.17
- Revenue Growth
- CHRS 52.33
- SFBC 8.26
- 52 Week Low
- CHRS $0.66
- SFBC $44.00
- 52 Week High
- CHRS $2.43
- SFBC $55.99
- Technical
- Relative Strength Index (RSI)
- CHRS 62.88
- SFBC 49.75
- Support Level
- CHRS $0.81
- SFBC $45.81
- Resistance Level
- CHRS $0.95
- SFBC $46.87
- Average True Range (ATR)
- CHRS 0.07
- SFBC 0.84
- MACD
- CHRS 0.01
- SFBC 0.10
- Stochastic Oscillator
- CHRS 85.71
- SFBC 29.09
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About SFBC Sound Financial Bancorp Inc.
Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.